<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04679636</url>
  </required_header>
  <id_info>
    <org_study_id>2-2020-1204</org_study_id>
    <nct_id>NCT04679636</nct_id>
  </id_info>
  <brief_title>Effects of HRV Biofeedback on Autonomic Function and Nicotine Withdrawal Symptoms and Dependence in Smoking Cessation Adults</brief_title>
  <official_title>Effects of Heart Rate Variability Biofeedback on Promoting Autonomic Function and Decreasing Nicotine Withdrawal Symptoms and Dependence in Smoking Cessation Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Defense Medical Center, Taiwan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Defense Medical Center, Taiwan</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a randomized controlled trial. It is estimated that 80 quitters will be&#xD;
      recruited, and they will be randomly included in the experimental group and 40 in the control&#xD;
      group. The experimental group will be involved in heart rate variability biological feedback&#xD;
      training for eight weeks, and the control group will receive conventional treatment. Use the&#xD;
      scale to assess the symptoms of nicotine withdrawal-anxiety, depression and insomnia, as well&#xD;
      as the degree of nicotine dependence before and after the intervention; the autonomic nervous&#xD;
      function of the participants was measured by heart rhythm variation before and after the&#xD;
      intervention; in addition, the cessation of smoking was tracked by telephone once a month for&#xD;
      six Months. Discuss interventional biological feedback training and evaluate its&#xD;
      effectiveness in improving heart rate variability, which represents autonomic nervous&#xD;
      function, and alleviating nicotine withdrawal anxiety, insomnia, and depression symptoms, as&#xD;
      well as nicotine dependence.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Smoking cessation has been one of the priorities in public health for many years, because the&#xD;
      severity of the disease and the social and economic losses caused by smoking cannot be&#xD;
      ignored. Among them, nicotine dependence is one of the important issues in quitting smoking.&#xD;
      Nicotine withdrawal symptoms often make the quitters' actions fail, especially anxiety,&#xD;
      insomnia, and depression, which further affect the lives of quitters. If an intervention can&#xD;
      be provided to improve the nicotine withdrawal symptoms of quitters and reduce nicotine&#xD;
      dependence, it should be able to improve the effectiveness of smoking cessation.This study is&#xD;
      a randomized controlled trial to facilitate sampling. It is expected that 80 quitters will be&#xD;
      recruited at the smoking cessation clinic of the medical center through the referral of the&#xD;
      attending physician, and 40 will be randomly included in the experimental group and the&#xD;
      control group. The experimental group will receive biofeedback training for heart rate&#xD;
      variability for eight weeks, while the control group will receive conventional treatment. Use&#xD;
      the scale to assess nicotine withdrawal symptoms before and after intervention-the degree of&#xD;
      anxiety (Beck Anxiety Inventory), depression (Beck Depression Inventory) and insomnia&#xD;
      (Pittsburgh Sleep Quality Index), And the degree of nicotine dependence (Nicotine Dependence&#xD;
      Scale; Fagerstrom Test for Nicotine Dependence); the autonomic nerve function of the&#xD;
      participants was measured by heart rhythm variability before and after the intervention; in&#xD;
      addition, the cessation of smoking was tracked by telephone once a month for six months. This&#xD;
      study is mainly to explore interventional biological feedback training to evaluate its&#xD;
      effectiveness in improving the representative autonomic nervous function-heart rate&#xD;
      variability and alleviating nicotine withdrawal anxiety, insomnia and depression symptoms and&#xD;
      nicotine dependence.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 26, 2020</start_date>
  <completion_date type="Anticipated">March 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>autonomic nerve function</measure>
    <time_frame>baseline</time_frame>
    <description>heart rate variability index</description>
  </primary_outcome>
  <primary_outcome>
    <measure>autonomic nerve function</measure>
    <time_frame>1 month</time_frame>
    <description>heart rate variability index</description>
  </primary_outcome>
  <primary_outcome>
    <measure>autonomic nerve function</measure>
    <time_frame>2 month</time_frame>
    <description>heart rate variability index</description>
  </primary_outcome>
  <primary_outcome>
    <measure>autonomic nerve function</measure>
    <time_frame>6 month</time_frame>
    <description>heart rate variability index</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>symptom distress(Anxiety)</measure>
    <time_frame>baseline</time_frame>
    <description>Beck Anxiety Inventory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>symptom distress(Anxiety)</measure>
    <time_frame>1 month</time_frame>
    <description>Beck Anxiety Inventory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>symptom distress(Anxiety)</measure>
    <time_frame>2 month</time_frame>
    <description>Beck Anxiety Inventory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>symptom distress(Anxiety)</measure>
    <time_frame>6 month</time_frame>
    <description>Beck Anxiety Inventory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>symptom distress(Depression)</measure>
    <time_frame>baseline</time_frame>
    <description>Beck Depression Inventory-II</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>symptom distress(Depression)</measure>
    <time_frame>1 month</time_frame>
    <description>Beck Depression Inventory-II</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>symptom distress(Depression)</measure>
    <time_frame>2 month</time_frame>
    <description>Beck Depression Inventory-II</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>symptom distress(Depression)</measure>
    <time_frame>6 month</time_frame>
    <description>Beck Depression Inventory-II</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>symptom distress(Sleep)</measure>
    <time_frame>baseline</time_frame>
    <description>Pittsburgh Sleep Quality Index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>symptom distress(Sleep)</measure>
    <time_frame>1 month</time_frame>
    <description>Pittsburgh Sleep Quality Index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>symptom distress(Sleep)</measure>
    <time_frame>2 month</time_frame>
    <description>Pittsburgh Sleep Quality Index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>symptom distress(Sleep)</measure>
    <time_frame>6 month</time_frame>
    <description>Pittsburgh Sleep Quality Index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cigarette Dependence</measure>
    <time_frame>baseline</time_frame>
    <description>Short-Form Cigarette Dependence Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cigarette Dependence</measure>
    <time_frame>1 month</time_frame>
    <description>Short-Form Cigarette Dependence Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cigarette Dependence</measure>
    <time_frame>2 month</time_frame>
    <description>Short-Form Cigarette Dependence Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cigarette Dependence</measure>
    <time_frame>6 month</time_frame>
    <description>Short-Form Cigarette Dependence Questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Heart Rate Variability, Biofeedback, Nicotine Dependence, Nicotine Withdrawal, Anxiety, Depression, Insomnia</condition>
  <arm_group>
    <arm_group_label>Experimental group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>receive biofeedback training for heart rate variability for eight weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>receive conventional treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>heart rate variability biofeedback</intervention_name>
    <description>receive biofeedback training for heart rate variability for eight weeks</description>
    <arm_group_label>Experimental group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Willing to quit smoking&#xD;
&#xD;
          2. Clear consciousness&#xD;
&#xD;
          3. Able to communicate in Mandarin or Taiwanese&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Diagnosed with asthma or chronic obstructive pulmonary disease&#xD;
&#xD;
          2. Diagnosed with nervous system&#xD;
&#xD;
          3. Diagnosis of mental illness&#xD;
&#xD;
          4. Arrhythmia, use of cardiac pacemakers, and atrioventricular conduction disorders&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Tri-Service Medical Center</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yu-Ju Chen, Ph.D.</last_name>
      <phone>886-2-87923100</phone>
      <phone_ext>18762</phone_ext>
      <email>judychen37@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>December 18, 2020</study_first_submitted>
  <study_first_submitted_qc>December 18, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 22, 2020</study_first_posted>
  <last_update_submitted>March 1, 2021</last_update_submitted>
  <last_update_submitted_qc>March 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Defense Medical Center, Taiwan</investigator_affiliation>
    <investigator_full_name>Yu-Ju Chen</investigator_full_name>
    <investigator_title>Dean of nursing</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tobacco Use Disorder</mesh_term>
    <mesh_term>Substance Withdrawal Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

